4//SEC Filing
GARDINER SANDRA A. 4
Accession 0001209191-21-022928
CIK 0001625101other
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 6:18 PM ET
Size
10.7 KB
Accession
0001209191-21-022928
Insider Transaction Report
Form 4
GARDINER SANDRA
CFO & EVP Admin. and Finance
Transactions
- Award
Stock Option (right to buy)
2021-03-22+18,000→ 18,000 totalExercise: $24.03From: 2022-03-01Exp: 2031-03-22→ Common Stock (18,000 underlying) - Award
Stock Option (right to buy)
2021-02-23+8,750→ 8,750 totalExercise: $10.66Exp: 2030-05-18→ Common Stock (8,750 underlying) - Award
Stock Option (right to buy)
2020-12-09+25,961→ 25,961 totalExercise: $13.94Exp: 2029-11-18→ Common Stock (25,961 underlying)
Footnotes (3)
- [F1]Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met with respect to performance-based stock options granted to the Reporting Person on November 18, 2019.
- [F2]Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met in 2020 with respect to performance-based stock options granted to the Reporting Person on May 18, 2020.
- [F3]The shares subject to the option will vest in equal annual installments over the following four years on the anniversary of March 1, 2021, subject to the Reporting Person's continued service through each vesting date.
Documents
Issuer
Pulse Biosciences, Inc.
CIK 0001625101
Entity typeother
Related Parties
1- filerCIK 0001218574
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 6:18 PM ET
- Size
- 10.7 KB